Skip to main content
Organon & Co. logo

Organon & Co. — Investor Relations & Filings

Ticker · OGN ISIN · US68622V1061 LEI · 549300AMCKY57OK2CO56 US Manufacturing
Filings indexed 423 across all filing types
Latest filing 2026-05-29 Environmental & Social …
Country US United States of America
Listing US OGN

About Organon & Co.

https://www.organon.com/

Organon & Co. is a global healthcare company dedicated to improving the health of women. The company's portfolio is structured around three core pillars: Women's Health, Biosimilars, and Established Brands. The Women's Health division focuses on reproductive health, including contraception and fertility, as well as other conditions unique to women. The Biosimilars business aims to provide more accessible treatment options, particularly in oncology and immunology. The Established Brands unit manages a diverse range of therapies for conditions such as cardiovascular disease, respiratory illnesses, dermatology, and neurology. Organon's portfolio includes more than 70 medicines and devices, which are available in over 140 markets.

Recent filings

Filing Released Lang Actions
FORM SD
Environmental & Social Information Classification · 85% confidence The document is a U.S. SEC Form SD (“Specialized Disclosure Report”) specifically disclosing the company’s conflict minerals due diligence process and findings, which falls under the company’s environmental/social governance disclosures. It is not an earnings release, annual/interim report, proxy, or simple announcement; it contains substantive ESG‐related content. Therefore it best fits the Environmental & Social Information category (SR).
2026-05-29 English
10-Q - Organon & Co. (0001821825) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-04 English
8-K - Organon & Co. (0001821825) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and includes a press release dated April 30, 2026, regarding quarterly results for the period ended March 31, 2026. The document states that the press release is included as Exhibit 99.1 and is considered "furnished" rather than "filed." The length of the document is 4330 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than containing detailed financial statements or analysis itself. According to the classification rules, initial announcements of quarterly financial results with key highlights only are classified as Earnings Release (ER). This document fits that description as it announces the earnings release and includes the press release as an exhibit. Therefore, the appropriate classification is Earnings Release (ER).
2026-04-30 English
8-K - Organon & Co. (0001821825) (Filer)
M&A Activity Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 26, 2026, by Organon & Co. The content describes the entry into a Material Definitive Agreement, specifically a Merger Agreement with Sun Pharmaceutical Holdings USA, Inc. It details the terms of the merger, including the merger consideration, treatment of equity awards, conditions for consummation, and termination rights. The document also mentions the delisting of shares from the NYSE upon completion of the merger. The primary focus is on the announcement and details of a merger transaction rather than a full annual or quarterly report, audit, or earnings release. This fits the category of M&A Activity filings, which cover announcements and documents related to merger proposals or takeover bids. The document is substantive and detailed, not merely an announcement of a report or a brief notice, so it is not an RPA or RNS. Therefore, the appropriate classification is M&A Activity (TAR).
2026-04-27 English
4 - ORGANON & CO. (0001821825) (Filer)
Director's Dealing
2026-03-03 English
4 - ORGANON & CO. (0001821825) (Filer)
Director's Dealing
2026-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.